TGF-β Superfamily Ligand Binding Profile-Based Applications
Legal Citation
Summary of the Inventive Concept
The inventive concept leverages the core technology of the original patent, applying ALK4:ActRIIB heteromultimers to modulate TGF-β superfamily signaling in novel industries, including agriculture, industrial chemistry, water quality monitoring, personalized prosthetics, and oil recovery.
Background and Problem Solved
The original patent addressed spinal muscular atrophy (SMA) by utilizing recombinant ALK4:ActRIIB heteromultimers. However, the potential of this technology extends beyond SMA treatment. The new inventive concept solves the problem of limited application scope by exploring alternative uses for ALK4:ActRIIB heteromultimers in various fields.
Detailed Description of the Inventive Concept
The inventive concept encompasses a range of applications, including: (1) a system for monitoring and predicting agricultural crop yields by analyzing soil nutrient levels through TGF-β superfamily ligand binding profiles; (2) a method for optimizing industrial chemical reactions by modulating TGF-β superfamily signaling using ALK4:ActRIIB heteromultimers; (3) a device for detecting and diagnosing waterborne pathogens via a biosensor incorporating ALK4:ActRIIB heteromultimers; (4) a system for generating personalized 3D-printed prosthetics by optimizing prosthetic design and fit through TGF-β superfamily ligand binding profiles; and (5) a method for enhancing oil recovery from existing wells by modulating TGF-β superfamily signaling using ALK4:ActRIIB heteromultimers. These applications capitalize on the versatility of ALK4:ActRIIB heteromultimers in regulating TGF-β superfamily signaling.
Novelty and Inventive Step
The new claims introduce a novel and non-obvious application of ALK4:ActRIIB heteromultimers beyond SMA treatment, demonstrating an inventive step in adapting the core technology to address distinct problems in various industries.
Alternative Embodiments and Variations
Alternative embodiments may include the use of different TGF-β superfamily ligands, variations in the design of the biosensor or algorithm, or the application of ALK4:ActRIIB heteromultimers in additional industries, such as environmental monitoring or biotechnology.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in multiple industries, including agriculture, industrial chemistry, water quality monitoring, personalized prosthetics, and oil recovery. The market for these applications is substantial, with potential customers including agricultural companies, chemical manufacturers, water treatment facilities, prosthetic manufacturers, and oil extraction companies.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K38/1841 |
| A | A61 | A61K31/7125 |
| A | A61 | A61K38/18 |
| A | A61 | A61K45/06 |
| A | A61 | A61P21/00 |
| C | C07 | C07K14/71 |
| C | C12 | C12N15/113 |
| A | A61 | A61K38/179 |
| C | C07 | C07K2319/30 |
| C | C07 | C07K2319/32 |
| C | C12 | C12N2310/11 |
| C | C12 | C12N2320/31 |
Original Patent Information
| Patent Number | US 11,857,599 |
|---|---|
| Title | Compositions and methods for treating spinal muscular atrophy |
| Assignee(s) | ACCELERON PHARMA INC. |